Azilsartan D4
| Product Name | Azilsartan D4 |
|---|---|
| Alternate Names | Azilsartan Stable Isotopes, Stable Isotopes of Azilsartan |
| CAT No. | CS-O-10156 |
| CAS No. | 1794817-45-0 |
| Category | Stable Isotopes |
| Stock | IN-Stock |
| Mol. Wt. | 460.5 g/mol |
| Mol. For. | C25H16N4O5D4 |
| Hazardous | This is not a Hazardous Compound |
| COA | View Sample COA |
| MSDS | View Sample MSDS |
| Parent API | Azilsartan |
| Purity | >98% |
| Therapeutic | Anti-Hypertensives |
| Smileys | OC(C1=C2N(C(OCC)=NC2=CC=C1)CC(C([2H])=C3[2H])=C(C([2H])=C3C4=C(C(N5)=NOC5=O)C=CC=C4)[2H])=O |
| Canonical Smiles | CCOC1=NC2=CC=CC(=C2N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NOC(=O)N5)C(=O)O |
| InchIKey | KGSXMPPBFPAXLY-ZGAVCIBUSA-N |
| Inchl | InChI=1S/C25H20N4O5/c1-2-33-24-26-20-9-5-8-19(23(30)31)21(20)29(24)14-15-10-12-16(13-11-15)17-6-3-4-7-18(17)22-27-25(32)34-28-22/h3-13H,2,14H2,1H3,(H,30,31)(H,27,28,32)/i10D,11D,12D,13D |
| IUPAC | 2-ethoxy-3-[[2,3,5,6-tetradeuterio-4-[2-(5-oxo-4H-1,2,4-oxadiazol-3-yl)phenyl]phenyl]methyl]benzimidazole-4-carboxylic acid |
| Controlled | No |
| Shipping | Free for purchase above 1000$ |
| Delivery | In-Stock, products will be dispatched within 24 hours via FedEx for USA, Europe, and other countries. |
| Return | Returns/replacement accepted if you are not satisfied with the quality of the product, (please send us an email with the reason/issues which are facing, within 15 days, after receipt of the product). |
| Ordering | Place your order online or by email sales@clearsynth.com |
Azilsartan D4 is a deuterated version of the anti-hypertensive drug Azilsartan, which is primarily used for the treatment of high blood pressure. Azilsartan D4 is a selective angiotensin II type 1 receptor blocker, which means it blocks the vasoconstrictor and aldosterone-secreting effects of angiotensin II. This results in the relaxation of blood vessels and a decrease in blood pressure.
The chemical formula of Azilsartan D4 is C25H18D4N4O5, with a molecular weight of 470.54 g/mol. The drug is typically administered orally in the form of tablets, with a recommended dosage of 40mg once a day. Azilsartan D4 is metabolized in the liver and excreted through the kidneys.
Studies have shown that Azilsartan D4 has a longer half-life and greater bioavailability than non-deuterated Azilsartan, which allows for a more consistent and effective treatment of hypertension. It has also been shown to be effective in reducing urinary albumin excretion, which is a marker of kidney damage in patients with type 2 diabetes.
Like all medications, Azilsartan D4 can have potential side effects including dizziness, fatigue, headache, and gastrointestinal disturbances. It is important to consult with a healthcare professional before taking Azilsartan D4, especially if one has a history of liver or kidney disease, or if they are pregnant or breastfeeding.
Get an Instant Quote
Related Compounds
Azilsartan D5 |